SLE disease patterns in a Danish population-based lupus cohort: an 8-year prospective study
暂无分享,去创建一个
A. Voss | H. Laustrup | P. Junker | A. Green
[1] J. Marenco,et al. Hospitalization of individuals with systemic lupus erythematosus: An analysis of 84 patients , 2011 .
[2] A. Voss,et al. Occurrence of systemic lupus erythematosus in a Danish community: an 8‐year prospective study , 2009, Scandinavian journal of rheumatology.
[3] S. Appenzeller,et al. Greater accrual damage in late-onset systemic lupus erythematosus: a long-term follow-up study , 2008, Lupus.
[4] Agustín R. Uribe,et al. Adolescent onset of lupus results in more aggressive disease and worse outcomes: results of a nested matched case–control study within LUMINA, a multiethnic US cohort (LUMINA LVII) , 2008, Lupus.
[5] S. Sone,et al. Observations on the occurrence of exacerbations in clinical course of systemic lupus erythematosus. , 2008, The journal of medical investigation : JMI.
[6] P. Emery,et al. The validity of the inclusion of "lupus headache" in the Systemic Lupus Erythematosus Disease Activity Index. , 2007, Arthritis and rheumatism.
[7] J. Reveille,et al. Systemic lupus erythematosus in a multiethnic US cohort: XLIII. The significance of thrombocytopenia as a prognostic factor. , 2007, Arthritis and rheumatism.
[8] U. Dafni,et al. Thrombocytopaenia in lupus as a marker of adverse outcome--seeking Ariadne's thread. , 2006, Rheumatology.
[9] H. Nossent,et al. Damage accumulation in systemic lupus erythematosus and its relation to disease activity and mortality. , 2006, The Journal of rheumatology.
[10] J. Reveille,et al. Systemic lupus erythematosus in a multiethnic US cohort. XXXIII. Clinical [corrected] features, course, and outcome in patients with late-onset disease. , 2006, Arthritis and rheumatism.
[11] O. Rekvig,et al. Prior anti-dsDNA antibody status does not predict later disease manifestations in systemic lupus erythematosus , 2006, Clinical Rheumatology.
[12] J. Reveille,et al. Systemic lupus erythematosus in a multiethnic cohort: LUMINA XXXV. Predictive factors of high disease activity over time , 2006, Annals of the rheumatic diseases.
[13] N. Arden,et al. Hospitalization of individuals with systemic lupus erythematosus: characteristics and predictors of outcome , 2003, Lupus.
[14] M. Vilardell,et al. Contribution of the initial features of systemic lupus erythematosus to the clinical evolution and survival of a cohort of Mediterranean patients , 2003, Annals of the rheumatic diseases.
[15] C. Gordon,et al. The SLICC Damage Index: past, present and future , 2002, Lupus.
[16] D. Gladman,et al. Systemic lupus erythematosus disease activity index 2000. , 2002, The Journal of rheumatology.
[17] L. Magder,et al. Decreases in anti-double-stranded DNA levels are associated with concurrent flares in patients with systemic lupus erythematosus. , 2001, Arthritis and rheumatism.
[18] T. Kvien,et al. Disease course in systemic lupus erythematosus: changes in health status, disease activity, and organ damage after 2 years. , 2001, The Journal of rheumatology.
[19] R Fischer,et al. Systemic lupus erythematosus. Disease outcome in patients with a disease duration of at least 10 years: second evaluation , 2001, Lupus.
[20] T. Witte,et al. Prognostic parameters for flare in systemic lupus erythematosus. , 2000, Rheumatology.
[21] C. Lau,et al. A prospective study of survival and prognostic indicators of systemic lupus erythematosus in a southern Chinese population. , 2000, Rheumatology.
[22] M. Liang,et al. Association between clinical factors, socioeconomic status, and organ damage in recent onset systemic lupus erythematosus. , 2000, The Journal of rheumatology.
[23] O. Nived,et al. Incidence studies of systemic lupus erythematosus in Southern Sweden: increasing age, decreasing frequency of renal manifestations and good prognosis. , 2000, The Journal of rheumatology.
[24] D. Gladman,et al. Accurately describing changes in disease activity in Systemic Lupus Erythematosus. , 2000, The Journal of rheumatology.
[25] F. Formiga,et al. Mild presentation of systemic lupus erythematosus in elderly patients assessed by SLEDAI , 1999, Lupus.
[26] J. Nossent,et al. SLICC/ACR Damage Index in Afro-Caribbean patients with systemic lupus erythematosus: changes in and relationship to disease activity, corticosteroid therapy, and prognosis. , 1998, The Journal of rheumatology.
[27] C. Gordon,et al. A Damage Index for Lupus Patients — Where are we now? , 1997, Lupus.
[28] D. Isenberg,et al. The occurrence, nature and distribution of flares in a cohort of patients with systemic lupus erythematosus: a rheumatological view. , 1995, British journal of rheumatology.
[29] A. Drosos,et al. Systemic Lupus Erythematosus in Greece. Clinical Features, Evolution and Outcome: a Descriptive Analysis of 292 Patients , 1993, Lupus.
[30] M. Petri,et al. Definition, incidence, and clinical description of flare in systemic lupus erythematosus. A prospective cohort study. , 1991, Arthritis and rheumatism.
[31] R. Panush,et al. Incomplete lupus erythematosus. , 1989, Archives of internal medicine.
[32] J. Nossent,et al. Systemic lupus erythematosus. II. Observations on the occurrence of exacerbations in the disease course: Dutch experience with 110 patients studied prospectively. , 1989, Annals of the rheumatic diseases.
[33] O. Nived,et al. Outcome in Systemic Lupus Erythematosus: A Prospective Study of Patients from a Defined Population , 1989, Medicine.
[34] A. Wiik. The value of specific ANA determination in rheumatology , 1987, Allergy.
[35] J. Mccrea,et al. Measurement of anti-cardiolipin antibodies by an enzyme-linked immunosorbent assay (ELISA): standardization and quantitation of results. , 1985, Clinical and experimental immunology.
[36] J F Fries,et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. , 1982, Arthritis and rheumatism.
[37] B. Thiers. The Effect of Combined Estrogen and Progesterone Hormone Replacement Therapy on Disease Activity in Systemic Lupus Erythematosus: A Randomized Trial , 2006 .
[38] C. Lau,et al. Do flares of systemic lupus erythematosus decline after menopause? , 1999, Scandinavian journal of rheumatology.
[39] A. Voss,et al. Systemic lupus erythematosus in Denmark: clinical and epidemiological characterization of a county-based cohort. , 1998, Scandinavian journal of rheumatology.
[40] A. Camargo-Coronel,et al. Measurement of clinical activity of systemic lupus erythematosus and laboratory abnormalities: a 12-month prospective study. , 1995, The Journal of rheumatology.
[41] H. Holman,et al. Systemic lupus erythematosus: a clinical analysis. , 1975, Major problems in internal medicine.